Pharmacist Led Intervention in the Management of Anemia Among Pregnant Woman

Anemia is a major public health problem among pregnant women, particularly in low‐ andmiddle‐income countries. It is characterized by a reduction in hemoglobin concentrationor the oxygen‐carrying capacity of the blood, which may be insufficient to meet thephysiological needs of the body. Maternal anemia is associated with an increased risk ofadverse maternal and fetal outcomes.Despite the high prevalence of anemia among pregnant women, poor medication adherence andinadequate understanding of prescribed therapy may limit treatment effectiveness.Pharmacists can play an important role in providing medication‐related education,improving patients' understanding of their treatment, identifying barriers to adherence,and promoting appropriate medication use. However, evidence on pharmacist‐led educationalinterventions to improve medication adherence and hemoglobin levels among anemic pregnantwomen in Pakistan remains limited.Therefore, this randomized controlled trial will be conducted to evaluate the effect of astructured pharmacist‐led educational intervention on medication adherence and hemoglobinlevels among anemic pregnant women in District Chakwal, Punjab, Pakistan.A total of 100 eligible pregnant women diagnosed with anemia will be recruited andrandomly allocated into intervention and control groups. Participants in the interventiongroup will receive a structured pharmacist‐led educational intervention in addition toroutine care, while participants in the control group will receive routine antenatal careand standard anemia management.Medication adherence and hemoglobin levels will be assessed at baseline and after theintervention. The study will determine whether pharmacist‐led educational counselingimproves medication adherence and hemoglobin levels compared with routine care.Data will be analyzed using IBM SPSS Statistics version 26. A paired‐sample t‐test willbe used to compare changes in continuous variables, particularly hemoglobin levels,between baseline and post‐intervention assessments. McNemar's test will be used to assesschanges in paired categorical variables, including medication adherence whereappropriate. A p‐value of <0.05 will be considered statistically significant.